Cargando…

Attention‐deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta‐analysis

Attention‐deficit/hyperactivity disorder (ADHD) often co‐occurs with other psychiatric and physical diseases. However, available evidence on associations between ADHD and cardiovascular diseases (CVDs) is mixed. To systematically review, quantitatively synthesize, and appraise available evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lin, Yao, Honghui, Zhang, Le, Garcia‐Argibay, Miguel, Du Rietz, Ebba, Brikell, Isabell, Solmi, Marco, Cortese, Samuele, Ramos‐Quiroga, J. Antoni, Ribasés, Marta, Chang, Zheng, Larsson, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501695/ https://www.ncbi.nlm.nih.gov/pubmed/37720588 http://dx.doi.org/10.1002/jcv2.12158

Ejemplares similares

Cardiovascular risk factors in attention‐deficit/hyperactivity disorder: A family design study of Swedish conscripts
por: Garcia‐Argibay, Miguel, et al.
Publicado: (2022)

Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis
por: Zhang, Le, et al.
Publicado: (2022)

Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder
por: Dobrosavljevic, Maja, et al.
Publicado: (2022)

Attention-deficit/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: A population-based register study
por: Dobrosavljevic, Maja, et al.
Publicado: (2021)

Predicting childhood and adolescent attention-deficit/hyperactivity disorder onset: a nationwide deep learning approach
por: Garcia-Argibay, Miguel, et al.
Publicado: (2022)

The association between polygenic scores for attention‐deficit/hyperactivity disorder and school performance: The role of attention‐deficit/hyperactivity disorder symptoms, polygenic scores for educational attainment, and shared familial factors
por: Jangmo, Andreas, et al.
Publicado: (2021)

Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes
por: Soler Artigas, María, et al.
Publicado: (2022)

Transcriptomic risk scores for attention deficit/hyperactivity disorder
por: Cabana-Domínguez, Judit, et al.
Publicado: (2023)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan
por: Vilar-Ribó, Laura, et al.
Publicado: (2023)

Attention-deficit/hyperactivity disorder symptoms and subsequent cardiometabolic disorders in adults: investigating underlying mechanisms using a longitudinal twin study
por: Dobrosavljevic, Maja, et al.
Publicado: (2023)

Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder
por: Richarte, Vanesa, et al.
Publicado: (2021)

The role of ADHD genetic risk in mid-to-late life somatic health conditions
por: Garcia-Argibay, Miguel, et al.
Publicado: (2022)

Correction: The role of ADHD genetic risk in mid-to-late life somatic health conditions
por: Garcia-Argibay, Miguel, et al.
Publicado: (2022)

Epigenome-wide association study of attention-deficit/hyperactivity disorder in adults
por: Rovira, Paula, et al.
Publicado: (2020)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016
por: Cortese, Samuele, et al.
Publicado: (2017)

Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Cabana-Domínguez, Judit, et al.
Publicado: (2022)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Genetics of attention deficit hyperactivity disorder
por: Faraone, Stephen V., et al.
Publicado: (2018)

Association of Polygenic Risk for Attention-Deficit/Hyperactivity Disorder With Co-occurring Traits and Disorders
por: Du Rietz, Ebba, et al.
Publicado: (2018)

Cortisol Response to Stress in Adults with Attention Deficit Hyperactivity Disorder
por: Corominas-Roso, Margarida, et al.
Publicado: (2015)

Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring
por: Christensen, Jakob, et al.
Publicado: (2019)

Prevalence of sleep disorder diagnoses and sleep medication prescriptions in individuals with ADHD across the lifespan: a Swedish nationwide register-based study
por: Ahlberg, Rickard, et al.
Publicado: (2023)

Attention-Deficit/Hyperactivity Disorder in Looked-After Children: a Systematic Review of the Literature
por: Willis, Renece, et al.
Publicado: (2017)

Genome‐wide analyses of aggressiveness in attention‐deficit hyperactivity disorder
por: Brevik, Erlend J., et al.
Publicado: (2016)

Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study
por: Du Rietz, Ebba, et al.
Publicado: (2021)

Predictive validity of parent- and self-rated ADHD symptoms in adolescence on adverse socioeconomic and health outcomes
por: Du Rietz, Ebba, et al.
Publicado: (2017)

Early life injuries and the development of attention deficit/hyperactivity disorder
por: Wimberley, Theresa, et al.
Publicado: (2022)

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder
por: Garcia-Martínez, Iris, et al.
Publicado: (2017)

Polygenic association between attention-deficit/hyperactivity disorder liability and cognitive impairments
por: Vainieri, Isabella, et al.
Publicado: (2022)

Exome chip analyses in adult attention deficit hyperactivity disorder
por: Zayats, T, et al.
Publicado: (2016)

A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder
por: Martin, Joanna, et al.
Publicado: (2018)

Polygenic risk scores and early manifestations of attention‐deficit/hyperactivity disorder
por: Larsson, Henrik, et al.
Publicado: (2022)

Brain structural and functional substrates of ADGRL3 (latrophilin 3) haplotype in attention-deficit/hyperactivity disorder
por: Moreno-Alcázar, Ana, et al.
Publicado: (2021)

Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder: from little to very little
por: Cortese, Samuele
Publicado: (2020)

Attention-deficit/hyperactivity disorder and impairment in executive functions: a barrier to weight loss in individuals with obesity?
por: Cortese, Samuele, et al.
Publicado: (2013)

Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Buitelaar, Jan K, et al.
Publicado: (2009)

Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
por: Lannes, Alice, et al.
Publicado: (2022)

Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder
por: Hoekzema, Elseline, et al.
Publicado: (2012)

The association between attention-deficit/hyperactivity (ADHD) symptoms and self-employment
por: Verheul, Ingrid, et al.
Publicado: (2016)

Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis
por: Cortese, Samuele, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f0078nshbgjq3remh8vnmb28g8